Johnson & Johnson JNJ MEDTECH — D&A

Other segment segments

Similar metrics at other companies

KNMedTech & Specialty Audio — D&A

$2.13M+2.4%

AVT

AVTRBioscience & Medtech Products — D&A

$49.2M+12.3%

ASSTMedical Device — D&A

$32K—

MIRMedical Segment — D&A

$16.2M-1.2%

CSPITechnology Solutions — D&A

$51K+24.4%

TTECTtec Digital — D&A

$6.33M-2.6%

Questions, answered.

What is Johnson & Johnson's MEDTECH — D&A?

Johnson & Johnson (JNJ) reported MEDTECH — D&A of $903M in Q1 2026.

How has Johnson & Johnson's MEDTECH — D&A changed year-over-year?

Johnson & Johnson's MEDTECH — D&A increased by 8.0% year-over-year, from $836M to $903M.

What is the long-term trend for Johnson & Johnson's MEDTECH — D&A?

Over 4 years (2021 to 2025), Johnson & Johnson's MEDTECH — D&A has grown at a 11.2% compound annual growth rate (CAGR), from $2.29B to $3.49B.

What does MEDTECH — D&A mean?

This is the combined non-cash expense representing the allocation of the cost of tangible and intangible assets over their useful lives within the medical technology segment. It accounts for the wear and tear of physical equipment and the expiration of intellectual property. This metric is essential for calculating EBITDA and understanding the segment's true cash-generating capability.